Quantification of the thermodynamically linked quaternary and tertiary structural stabilities of transthyretin and its disease-associated variants: the relationship between stability and amyloidosis.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Biochemistry

• Publication date

  2008-06-07

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/bi800636qPMID 18537267PMCID PMC2667099
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Biochemical and structural evaluation of highly selective 2-arylbenzoxazole-based transthyretin amyloidogenesis inhibitors.

  2008cited by this paper
• The unfolding pathway for Apo Escherichia coli aspartate aminotransferase is dependent on the choice of denaturant.

  2007cited by this paper
• An adaptable standard for protein export from the endoplasmic reticulum.

  2007cited by this paper
• Thermodynamic analysis of three state denaturation of Peanut Agglutinin

  2006cited by this paper
• Amyloidosis.

  2006cited by this paper
• Kinetic stabilization of the native state by protein engineering: implications for inhibition of transthyretin amyloidogenesis.

  2005cited by this paper
• Kinetic stabilization of an oligomeric protein by a single ligand binding event.

  2005cited by this paper
• The pathway by which the tetrameric protein transthyretin dissociates.

  2005cited by this paper
• Native state kinetic stabilization as a strategy to ameliorate protein misfolding diseases: a focus on the transthyretin amyloidoses.

  2005cited by this paper
• Partitioning conformational intermediates between competing refolding and aggregation pathways: insights into transthyretin amyloid disease.

  2005cited by this paper
• The biological and chemical basis for tissue-selective amyloid disease.

  2005cited by this paper
• Transthyretin aggregation under partially denaturing conditions is a downhill polymerization.

  2004cited by this paper
• Diflunisal analogues stabilize the native state of transthyretin. Potent inhibition of amyloidogenesis.

  2004cited by this paper
• Tissue damage in the amyloidoses: Transthyretin monomers and nonnative oligomers are the major cytotoxic species in tissue culture.

  2004cited by this paper
• Liver transplantation in transthyretin-related familial amyloid polyneuropathy

  2004cited by this paper
• Hydration and packing are crucial to amyloidogenesis as revealed by pressure studies on transthyretin variants that either protect or worsen amyloid disease.

  2003cited by this paper
• Benzoxazoles as transthyretin amyloid fibril inhibitors: synthesis, evaluation, and mechanism of action.

  2003cited by this paper
• Energetic Characteristics of the New Transthyretin Variant A25T May Explain Its Atypical Central Nervous System Pathology

  2003cited by this paper
• Prevention of Transthyretin Amyloid Disease by Changing Protein Misfolding Energetics

  2003cited by this paper
• D18G transthyretin is monomeric, aggregation prone, and not detectable in plasma and cerebrospinal fluid: a prescription for central nervous system amyloidosis?

  2003cited by this paper
• Equilibrium denaturation studies of the Escherichia coli factor for inversion stimulation: Implications for in vivo function

  2002cited by this paper
• Sequence-dependent denaturation energetics: A major determinant in amyloid disease diversity

  2002cited by this paper
• An engineered transthyretin monomer that is nonamyloidogenic, unless it is partially denatured.

  2001cited by this paper
• Deposition of transthyretin in early stages of familial amyloidotic polyneuropathy: evidence for toxicity of nonfibrillar aggregates.

  2001cited by this paper
• The V122I cardiomyopathy variant of transthyretin increases the velocity of rate-limiting tetramer dissociation, resulting in accelerated amyloidosis

  2001cited by this paper
• Anion shielding of electrostatic repulsions in transthyretin modulates stability and amyloidosis: insight into the chaotrope unfolding dichotomy.

  2001cited by this paper
• Tetramer Dissociation and Monomer Partial Unfolding Precedes Protofibril Formation in Amyloidogenic Transthyretin Variants*

  2001cited by this paper
• Transthyretin slowly exchanges subunits under physiological conditions: A convenient chromatographic method to study subunit exchange in oligomeric proteins

  2001cited by this paper
• Trans-Suppression of Misfolding in an Amyloid Disease

  2001cited by this paper
• Equilibrium folding of dimeric class mu glutathione transferases involves a stable monomeric intermediate.

  2000cited by this paper
• A comparative analysis of 23 structures of the amyloidogenic protein transthyretin.

  2000cited by this paper
• A glimpse of a possible amyloidogenic intermediate of transthyretin

  2000cited by this paper
• The genetics of the amyloidoses.

  2000cited by this paper
• Comparative calorimetric study of non-amyloidogenic and amyloidogenic variants of the homotetrameric protein transthyretin.

  2000cited by this paper
• The most pathogenic transthyretin variant, L55P, forms amyloid fibrils under acidic conditions and protofilaments under physiological conditions.

  1999cited by this paper
• The alternative conformations of amyloidogenic proteins and their multi-step assembly pathways.

  1998cited by this paper
• Structure and mechanism in protein science

  1998cited by this paper
• Organophosphorus hydrolase is a remarkably stable enzyme that unfolds through a homodimeric intermediate.

  1997cited by this paper
• Variant-sequence transthyretin (isoleucine 122) in late-onset cardiac amyloidosis in black Americans.

  1997cited by this paper
• Inhibiting transthyretin amyloid fibril formation via protein stabilization.

  1996cited by this paper
• Alternative conformations of amyloidogenic proteins govern their behavior.

  1996cited by this paper
• The acid-mediated denaturation pathway of transthyretin yields a conformational intermediate that can self-assemble into amyloid.

  1996cited by this paper
• Comparison of lethal and nonlethal transthyretin variants and their relationship to amyloid disease.

  1995cited by this paper
• Denaturant m values and heat capacity changes: Relation to changes in accessible surface areas of protein unfolding

  1995cited by this paper
• Transthyretin mutation Leu-55-Pro significantly alters tetramer stability and increases amyloidogenicity.

  1993cited by this paper
• A strikingly benign evolution of FAP in an individual found to be a compound heterozygote for two TTR mutations: TTR MET 30 and TTR MET 119

  1993cited by this paper
• Partial denaturation of transthyretin is sufficient for amyloid fibril formation in vitro.

  1992cited by this paper
• Transthyretin Pro55, a variant associated with early-onset, aggressive, diffuse amyloidosis with cardiac and neurologic involvement

  1992cited by this paper
• [Familial amyloidotic polyneuropathy].

  1990cited by this paper
• Fibril in senile systemic amyloidosis is derived from normal transthyretin.

  1990cited by this paper
• Familial amyloidotic polyneuropathy.

  1989cited by this paper
• Determination and analysis of urea and guanidine hydrochloride denaturation curves.

  1986cited by this paper

• Initiation of transthyretin aggregation at neutral pH by fluid agitation

  2025cites this paper
• Associations between pathophysiological traits and symptom development in retrospective analysis of V30M and V122I transthyretin amyloidosis

  2025cites this paper
• Mass spectrometry footprinting reveals how kinetic stabilizers counteract transthyretin dynamics altered by pathogenic mutations.

  2025cites this paper
• Lysine carbamoylation during urea denaturation remodels the energy landscape of human transthyretin dissociation linked to unfolding

  2025cites this paper
• New promising transthyretin stabilizers for cardiac amyloidosis treatment

  2025cites this paper
• Mechanism of inhibition of acid-mediated transthyretin aggregation by designed peptides

  2025cites this paper
• The establishment of specific reference intervals for serum transthyretin tetramer, misfolded proteins, and protein misfolding rate and its application in evaluating transthyretin amyloidosis patients.

  2025cites this paper
• The immune-evasive proline-283 substitution in influenza nucleoprotein increases aggregation propensity without altering the native structure

  2024cites this paper
• Conformational dynamics of an amyloidogenic intermediate of transthyretin: implications for structural remodeling and amyloid formation.

  2024cites this paper
• Cryo-EM confirms a common fibril fold in the heart of four patients with ATTRwt amyloidosis

  2024cites this paper
• Aggregation of Transthyretin by Fluid Agitation

  2024cites this paper
• Conservation of kinetic stability, but not the unfolding mechanism, between human transthyretin and a transthyretin-related enzyme

  2024cites this paper
• The Structural and Dynamic Insights into the Ala97Ser Amyloidogenic Mutation in Transthyretin.

  2024cites this paper
• Transthyretin Amyloidosis: Role of oxidative stress and the beneficial implications of antioxidants and nutraceutical supplementation.

  2024cites this paper
• Mispacking of the F87 sidechain drives aggregation‐promoting conformational fluctuations in the subunit interfaces of the transthyretin tetramer

  2024cites this paper
• Characterization of an amyloidogenic intermediate of transthyretin by NMR relaxation dispersion

  2024cites this paper
• Non-Cardiac Amyloidosis Findings Are Not Increased in African American Carriers of TTR V142I with Heart Failure and/or Arrhythmia

  2024cites this paper
• Mispacking of the F87 sidechain drives aggregation-promoting conformational fluctuations in the subunit interfaces of the transthyretin tetramer

  2024cites this paper
• Cryo-EM confirms a common fibril fold in the heart of four patients with ATTRwt amyloidosis

  2024cites this paper
• Identification of a novel transthyretin mutation D39Y in a cardiac amyloidosis patient and its biochemical characterizations

  2023cites this paper
• PITB: A high affinity transthyretin aggregation inhibitor with optimal pharmacokinetic properties.

  2023cites this paper
• The Immune-Evasive Proline 283 Substitution in Influenza Nucleoprotein Increases Aggregation Propensity Without Altering the Native Structure

  2023cites this paper
• Hydrogen bonds connecting the N-terminal region and the DE loop stabilize the monomeric structure of transthyretin.

  2023cites this paper
• Probing the dissociation pathway of a kinetically labile transthyretin mutant

  2023cites this paper
• Oral Therapy for the Treatment of Transthyretin-Related Amyloid Cardiomyopathy

  2022cites this paper
• Development of a Highly Potent Transthyretin Amyloidogenesis Inhibitor: Design, Synthesis, and Evaluation

  2022cites this paper
• In Vitro and In Vivo Effects of SerpinA1 on the Modulation of Transthyretin Proteolysis

  2021cites this paper
• Disease-associated mutations impacting BC-loop flexibility trigger long-range transthyretin tetramer destabilization and aggregation

  2021cites this paper
• The discovery and development of transthyretin amyloidogenesis inhibitors: what are the lessons?

  2021cites this paper
• A Brief Journey through Protein Misfolding in Transthyretin Amyloidosis (ATTR Amyloidosis)

  2021cites this paper
• Synthesis and biological evaluation of quinolone derivatives as transthyretin amyloidogenesis inhibitors and fluorescence sensors.

  2021cites this paper
• Thermodynamic Stability and Aggregation Kinetics of EF Helix and EF Loop Variants of Transthyretin.

  2021cites this paper
• From uncovering the mechanism of transthyretin aggregation to the drug tafamidis for ameliorating neurodegeneration and cardiomyopathy

  2021cites this paper
• Tolcapone, a potent aggregation inhibitor for the treatment of familial leptomeningeal amyloidosis

  2020cites this paper
• Targeting transthyretin ‐ Mechanism‐based treatment approaches and future perspectives in hereditary amyloidosis

  2020cites this paper
• Oligomerization Profile of Human Transthyretin Variants with Distinct Amyloidogenicity

  2020cites this paper
• Destabilisation of the structure of transthyretin is driven by Ca2.

  2020cites this paper
• Structure-activity relationships of flurbiprofen analogues as stabilizers of the amyloidogenic protein transthyretin.

  2019cites this paper
• A designed protein binding-pocket to control excited-state intramolecular proton transfer fluorescence.

  2019cites this paper
• A new metal affinity NCTR25 tag as a better alternative to the His-tag for the expression of recombinant fused proteins.

  2019cites this paper
• The α-synuclein hereditary mutation E46K unlocks a more stable, pathogenic fibril structure

  2019cites this paper
• Characterization of Non-amyloidogenic G101S Transthyretin.

  2018cites this paper
• Unusual duplication mutation in a surface loop of human transthyretin leads to an aggressive drug-resistant amyloid disease

  2018cites this paper
• Assessment of the effects of transthyretin peptide inhibitors in Drosophila models of neuropathic ATTR

  2018cites this paper
• NMR Measurements Reveal the Structural Basis of Transthyretin Destabilization by Pathogenic Mutations.

  2018cites this paper
• Amyloid seeding of transthyretin by ex vivo cardiac fibrils and its inhibition

  2018cites this paper
• Kinetic analysis of the multistep aggregation pathway of human transthyretin

  2018cites this paper
• The Role of Inflammation in Amyloid Diseases

  2018cites this paper
• Inhibition of amyloid beta fibril formation by monomeric human transthyretin

  2018cites this paper
• Noncerebral Amyloidoses: Aspects on Seeding, Cross-Seeding, and Transmission.

  2018cites this paper
• Pharmacological chaperones to prevent transthyretin amyloidosis

  2017cites this paper
• Studies of an unusual transthyretin protein (TTR GLU51_SER52DUP) associated with familial amyloidosis

  2017cites this paper
• Evaluating the effect of mutations and ligand binding on transthyretin homotetramer dynamics

  2017cites this paper
• Stabilization of protein-protein interactions in drug discovery

  2017cites this paper
• A current pharmacologic agent versus the promise of next generation therapeutics to ameliorate protein misfolding and/or aggregation diseases.

  2016cites this paper
• Peripheral Blood Cell Gene Expression Diagnostic for Identifying Symptomatic Transthyretin Amyloidosis Patients: Male and Female Specific Signatures

  2016cites this paper
• Novel conformation-specific monoclonal antibodies against amyloidogenic forms of transthyretin

  2016cites this paper
• A New Folding Kinetic Mechanism for Human Transthyretin and the Influence of the Amyloidogenic V30M Mutation

  2016cites this paper
• Selection of transthyretin amyloid inhibitors

  2016cites this paper
• Combined Isothermal Titration and Differential Scanning Calorimetry Define Three-State Thermodynamics of fALS-Associated Mutant Apo SOD1 Dimers and an Increased Population of Folded Monomer.

  2016cites this paper
• Systemic optimization and structural evaluation of quinoline derivatives as transthyretin amyloidogenesis inhibitors.

  2016cites this paper
• Transthyretin variants with improved inhibition of β-amyloid aggregation.

  2016influential citation
• Natural Modulators of Amyloid formation in Alzheimer's disease

  2016cites this paper
• Probing Conformational Stability and Dynamics of Erythroid and Nonerythroid Spectrin: Effects of Urea and Guanidine Hydrochloride

  2015cites this paper
• Targeting protein aggregation for the treatment of degenerative diseases

  2015cites this paper
• Structural evidence for asymmetric ligand binding to transthyretin.

  2015cites this paper
• Uncovering the Mechanism of Aggregation of Human Transthyretin

  2015cites this paper
• Pathological, biochemical, and biophysical characteristics of the transthyretin variant Y114H (p.Y134H) explain its very mild clinical phenotype

  2015cites this paper
• Characterizing the effect of transthyretin amyloid on the heart

  2015cites this paper
• The Structural Determinants of the Immunoglobulin Light Chain Amyloid Aggregation

  2015cites this paper
• Modulating inhibitors of transthyretin fibrillogenesis via sulfation: polychlorinated biphenyl sulfates as models.

  2015cites this paper
• Transthyretin Binding Heterogeneity and Anti-amyloidogenic Activity of Natural Polyphenols and Their Metabolites*

  2015cites this paper
• Personalized medicine approach for optimizing the dose of tafamidis to potentially ameliorate wild-type transthyretin amyloidosis (cardiomyopathy)

  2015cites this paper
• Recent progress in the understanding and treatment of transthyretin amyloidosis

  2014cites this paper
• Conformational flexibility tunes the propensity of transthyretin to form fibrils through non-native intermediate states.

  2014cites this paper
• Competitive inhibition reaction mechanisms for the two-step model of protein aggregation.

  2014cites this paper
• Protein fibrillation lag times during kinetic inhibition.

  2014cites this paper
• Cooperative Stabilization of Transthyretin by Clusterin and Diflunisal

  2014cites this paper
• Quantification of Quaternary Structure Stability in Aggregation-Prone Proteins under Physiological Conditions: The Transthyretin Case

  2014cites this paper
• Homozygosity for the V122I mutation in transthyretin is associated with earlier onset of cardiac amyloidosis in the African American population in the seventh decade of life.

  2014cites this paper
• Modulators of protein-protein interactions.

  2014cites this paper
• Toxicological and therapeutic implications of interactions between polychlorinated biphenyl sulfates and human transthyretin

  2014cites this paper
• Mechanisms of amyloid fibril-mediated toxicity

  2014cites this paper
• Cystatin C and Alzheimer's Disease

  2014cites this paper
• A Refined Method for Quantitation of Divalent Metal Ions in Metalloproteins and Local Stability and Conformational Heterogeneity of Amyotrophic Lateral Sclerosis-Associated Cu, Zn Superoxide Dismutase

  2014cites this paper
• Quantification of Transthyretin Kinetic Stability in Human Plasma Using Subunit Exchange

  2014cites this paper
• A complex equilibrium among partially unfolded conformations in monomeric transthyretin.

  2014cites this paper
• The impact of V30A mutation on transthyretin protein structural stability and cytotoxicity against neuroblastoma cells.

  2013cites this paper
• Transthyretin as both a sensor and a scavenger of β-amyloid oligomers.

  2013cites this paper
• Diagnostic hallmarks and pitfalls in late-onset progressive transthyretin-related amyloid-neuropathy

  2013cites this paper
• Invited review: Caseins and the casein micelle: their biological functions, structures, and behavior in foods.

  2013cites this paper
• Structure-Based Analysis of A19D, a Variant of Transthyretin Involved in Familial Amyloid Cardiomyopathy

  2013cites this paper
• Mechanisms of Transthyretin Inhibition of β-Amyloid Aggregation In Vitro

  2013cites this paper
• Aromatic sulfonyl fluorides covalently kinetically stabilize transthyretin to prevent amyloidogenesis while affording a fluorescent conjugate.

  2013cites this paper
• Localized structural fluctuations promote amyloidogenic conformations in transthyretin.

  2013cites this paper
• Tafamidis (Vyndaqel): A Light for FAP Patients

  2013cites this paper
• Development of Therapeutic Strategies for the Transthyretin Amyloidoses

  2013cites this paper
• Transthyretin is a metallopeptidase with an inducible active site.

  2012cites this paper
• Protein Aggregation and Fibrillogenesis in Cerebral and Systemic Amyloid Disease

  2012cites this paper
• Using Small Globular Proteins to Study Folding Stability and Aggregation

  2012cites this paper